Suppr超能文献

考拉大麻调查研究:癌症患者在治疗前后使用大麻的情况。

A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.

机构信息

Breastcancer.org, Ardmore, Pennsylvania.

Socanna, Narberth, Pennsylvania.

出版信息

Cancer. 2022 Jan 1;128(1):160-168. doi: 10.1002/cncr.33906. Epub 2021 Oct 12.

Abstract

BACKGROUND

The goal of this study was to characterize cannabis use among patients with breast cancer, including their reasons for and timing of use, their sources of cannabis information and products, their satisfaction with the information found, their perceptions of its safety, and their dialogue about cannabis with their physicians.

METHODS

United States-based members of the Breastcancer.org and Healthline.com communities with a self-reported diagnosis of breast cancer within 5 years (age ≥ 18 years) were invited to participate in an anonymous online survey. After informed consent was obtained, nonidentifiable data were collected and analyzed.

RESULTS

Of all participants (n = 612), 42% (n = 257) reported using cannabis for relief of symptoms, which included pain (78%), insomnia (70%), anxiety (57%), stress (51%), and nausea/vomiting (46%). Furthermore, 49% of cannabis users believed that medical cannabis could be used to treat cancer itself. Of those taking cannabis, 79% had used it during treatment, which included systemic therapies, radiation, and surgery. At the same time, few (39%) had discussed it with any of their physicians.

CONCLUSIONS

A significant percentage of survey participants (42%) used cannabis to address symptoms; approximately half of these participants believed that cannabis could treat cancer itself. Most participants used cannabis during active cancer treatment despite the potential for an adverse event during this vulnerable time. Furthermore, most participants believed that cannabis was safe and were unaware that product quality varied widely and depended on the source. This study reviews the research on medicinal cannabis in the setting of these findings to help physicians to recognize its risks and benefits for patients with cancer.

LAY SUMMARY

Almost half of patients with breast cancer use cannabis, most commonly during active treatment to manage common symptoms and side effects: pain, anxiety, insomnia, and nausea. However, most patients do not discuss cannabis use with their physicians. Instead, the internet and family/friends are the most common sources of cannabis information. Furthermore, most participants believe that cannabis products are safe and are unaware that the safety of many products is untested.

摘要

背景

本研究旨在描述乳腺癌患者的大麻使用情况,包括他们使用大麻的原因和时间、获取大麻信息和产品的来源、对所获取信息的满意度、对大麻安全性的看法,以及他们与医生就大麻进行的对话。

方法

本研究邀请了在美国的 Breastcancer.org 和 Healthline.com 社区成员参与一项匿名在线调查,这些成员自我报告在 5 年内被诊断出患有乳腺癌(年龄≥18 岁)。在获得知情同意后,收集并分析了不可识别的数据。

结果

在所有参与者中(n=612),42%(n=257)报告使用大麻缓解症状,包括疼痛(78%)、失眠(70%)、焦虑(57%)、压力(51%)和恶心/呕吐(46%)。此外,49%的大麻使用者认为医用大麻可用于治疗癌症本身。在使用大麻的人群中,79%的人在治疗期间使用过,包括系统治疗、放疗和手术。与此同时,很少(39%)人与任何医生讨论过此事。

结论

相当一部分调查参与者(42%)使用大麻来缓解症状;其中约一半参与者认为大麻可以治疗癌症本身。大多数参与者在癌症活跃期使用大麻,尽管在这个脆弱时期使用大麻有潜在的不良反应风险。此外,大多数参与者认为大麻是安全的,并且不知道产品质量差异很大,取决于来源。本研究回顾了医用大麻在这些发现背景下的研究,以帮助医生认识到其对癌症患者的风险和益处。

通俗总结

近一半的乳腺癌患者使用大麻,最常见的是在积极治疗期间,用于缓解常见的症状和副作用:疼痛、焦虑、失眠和恶心。然而,大多数患者不会与医生讨论大麻的使用情况。相反,互联网和家人/朋友是获取大麻信息的最常见来源。此外,大多数参与者认为大麻产品是安全的,并且不知道许多产品的安全性未经测试。

相似文献

1
A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.
Cancer. 2022 Jan 1;128(1):160-168. doi: 10.1002/cncr.33906. Epub 2021 Oct 12.
2
Cannabis use among adults undergoing cancer treatment.
Cancer. 2023 Nov 1;129(21):3498-3508. doi: 10.1002/cncr.34922. Epub 2023 Jun 24.
3
Cannabis use among cancer patients and survivors in the United States: a systematic review.
JNCI Cancer Spectr. 2024 Jan 4;8(1). doi: 10.1093/jncics/pkae004.
4
Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada.
Curr Oncol. 2019 Aug;26(4):e425-e432. doi: 10.3747/co.26.4743. Epub 2019 Aug 1.
7
A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment.
J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):290-297. doi: 10.1093/jncimonographs/lgae007.
8
Overview of cancer patient perspectives on cannabis use during treatment.
J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):199-201. doi: 10.1093/jncimonographs/lgae025.
9
Benefits and harms of medical cannabis: a scoping review of systematic reviews.
Syst Rev. 2019 Dec 10;8(1):320. doi: 10.1186/s13643-019-1243-x.

引用本文的文献

2
Patterns and factors among oncology fellows recommending medical cannabis to adults with cancer.
J Cannabis Res. 2025 Jul 14;7(1):45. doi: 10.1186/s42238-025-00293-9.
4
Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment.
Sci Rep. 2024 Nov 16;14(1):28319. doi: 10.1038/s41598-024-78501-4.
6
The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects.
Cancers (Basel). 2024 Aug 21;16(16):2909. doi: 10.3390/cancers16162909.
7
Cannabinoids and triple-negative breast cancer treatment.
Front Immunol. 2024 Aug 8;15:1386548. doi: 10.3389/fimmu.2024.1386548. eCollection 2024.
9
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers.
J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):202-217. doi: 10.1093/jncimonographs/lgae029.
10
The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis.
J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):244-251. doi: 10.1093/jncimonographs/lgad024.

本文引用的文献

1
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment.
Breast Cancer Res Treat. 2021 Feb;186(1):219-227. doi: 10.1007/s10549-020-06001-w. Epub 2020 Nov 5.
2
Cannabidiol (CBD) as a Promising Anti-Cancer Drug.
Cancers (Basel). 2020 Oct 30;12(11):3203. doi: 10.3390/cancers12113203.
3
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol.
Front Pharmacol. 2020 Sep 11;11:571832. doi: 10.3389/fphar.2020.571832. eCollection 2020.
4
Medical Cannabis in Cancer Patients: A Survey of a Community Hematology Oncology Population.
Am J Clin Oncol. 2020 Sep;43(9):636-639. doi: 10.1097/COC.0000000000000718.
5
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.
Cancers (Basel). 2020 Aug 28;12(9):2447. doi: 10.3390/cancers12092447.
6
Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
J Diet Suppl. 2020;17(5):599-607. doi: 10.1080/19390211.2020.1766634. Epub 2020 May 20.
8
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment.
Cancers (Basel). 2020 Feb 25;12(3):525. doi: 10.3390/cancers12030525.
9
Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
N Engl J Med. 2020 Feb 20;382(8):766-772. doi: 10.1056/NEJMsr1915313. Epub 2019 Dec 20.
10
Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.
N Engl J Med. 2020 Feb 20;382(8):697-705. doi: 10.1056/NEJMoa1916433. Epub 2019 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验